Comment on: Satoh-Asahara et al. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care 2012;35:2631–2639 | Zendy

Katsunori ogaki | Zendy

Open Access

Comment on: Satoh-Asahara et al. Highly Purified Eicosapentaenoic Acid Increases Interleukin-10 Levels of Peripheral Blood Monocytes in Obese Patients With Dyslipidemia. Diabetes Care 2012;35:2631–2639

Author(s) -

Katsunori ogaki

Publication year - 2013

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc13-0156

Subject(s) - medicine , dyslipidemia , eicosapentaenoic acid , pulse wave velocity , diabetes mellitus , arterial stiffness , endocrinology , type 2 diabetes , peripheral , interleukin 6 , arachidonic acid , gastroenterology , polyunsaturated fatty acid , blood pressure , inflammation , fatty acid , biochemistry , chemistry , enzyme

Satoh-Asahara et al. (1) recently reported that treatment with purified eicosapentaenoic acid (EPA; 1.8 g daily) for 3 months increases the serum EPA/arachidonic acid (AA) ratio and interleukin-10 levels of peripheral blood monocytes in association with slight decreases in the pulse wave velocity, an index of arterial stiffness, in obese patients with dyslipidemia. Pulse wave velocity values before treatment with or without EPA were almost within the age-associated normal range (around the age-associated healthy average + 1 SD) in these Japanese subjects. The clinical value of treatment with purified EPA for the primary prevention of atherosclerosis and/or cardiovascular disease, however, remains uncertain. …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research